Posaconazole hydrate is used as an antifungal agent; it exhibits potent activity against Candida and Aspergillus species resistant to fluconazole, voriconazole, and amphotericin B, and shows superior efficacy compared to other triazoles against zygomycetes; it also demonstrates potent trypanocidal activity against Trypanosoma cruzi by inhibiting ergosterol biosynthesis, disrupting Ca²⁺ homeostasis, and suppressing proliferation of both extracellular epimastigote and intracellular amastigote forms; in combination with amiodarone, it enhances anti-T. cruzi efficacy with reduced side effects; it is effective in vivo for reducing parasitemia, tissue burden, and improving survival in infected animals.